The United Laboratories International Holdings Limited
HKSE: 3933.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Hoi Shan Tsoi
- Employees
- 17,000
- Headquarters
- Yuen Long, Hong Kong SAR China
- IPO year
- 2007
- Market cap
- HK$19.5B
- Website
- https://www.tul.com.cn
Loading 3933…
Loading profile data…Frequently asked questions about 3933
What does The United Laboratories International Holdings Limited (3933.HK) do?
The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injec...
Where does 3933.HK trade?
The United Laboratories International Holdings Limited (3933.HK) trades on the Hong Kong Stock Exchange.
What sector is 3933.HK in?
The United Laboratories International Holdings Limited (3933.HK) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of The United Laboratories International Holdings Limited?
Hoi Shan Tsoi is the chief executive officer of The United Laboratories International Holdings Limited (3933.HK).
Where is The United Laboratories International Holdings Limited headquartered?
The United Laboratories International Holdings Limited is headquartered in Hong Kong SAR China.
Does 3933.HK pay a dividend?
Yes — The United Laboratories International Holdings Limited (3933.HK) paid a trailing twelve-month dividend of HKD 0.47 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 3933.HK go public?
The United Laboratories International Holdings Limited (3933.HK) completed its initial public offering in 2007.